1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Insmed Incorporated

Insmed Incorporated

INSM
Insmed IncorporatedUS flagNASDAQ Global Select
126.29
USD
-0.39
- -
27.37BMarket Cap

Total Valuation

Insmed Incorporated carries a market capitalization of 27.37B, placing it among publicly traded companies globally. Its enterprise value stands at 22.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap27.37B
Enterprise Value22.69B

Share Statistics

Insmed Incorporated currently has 218.28M shares outstanding.

Shares Outstanding218.28M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 20.11, and the price-to-book ratio stands at 30.72.

PE RatioN/A
PS Ratio20.11
PB Ratio30.72
P/TBV Ratio44.09
P/FCF Ratio-30.49
P/OCF Ratio-29.37

Enterprise Valuation

EV / Sales19.95
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Insmed Incorporated maintains a current ratio of 3.72, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 76.55, indicating elevated leverage, while an interest coverage ratio of -10.46 demonstrates limited ability to service its debt obligations.

Current Ratio3.72
Quick Ratio3.14
Debt / Equity76.55
Debt / EBITDA-0.73
Interest Coverage-10.46

Financial Efficiency

Return on Equity (ROE)-87.22
Return on Assets (ROA)-38.20
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.51

Taxes

Income Tax6.21M
Effective Tax RateN/A

Stock Price Statistics

Insmed Incorporated's stock has declined approximately -12.96347% over the past 52 weeks. The 50-day moving average sits at 115.69, while the 200-day moving average is 140.82.

Beta (5Y)N/A
52-Week Price Change-12.96347%
50-Day Moving Average115.69
200-Day Moving Average140.82
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Insmed Incorporated generated 1.14B in revenue and converted that into -875.31M in net income, yielding earnings per share of -4.08. EBITDA reached -792.82M, while operating income came in at -812.65M.

Revenue1.14B
Gross Profit949.42M
Operating Income-812.65M
Pretax Income-869.11M
Net Income-875.31M
EBITDA-792.82M
EBIT-812.65M
Earnings Per Share (EPS)-4.08

Balance Sheet

Insmed Incorporated holds 1.16B in cash and equivalents against 579.88M in total debt, resulting in a net debt position of -1.25M. Total book value stands at 757.49M, with working capital of 1.20B providing operational flexibility.

Cash & Cash Equivalents1.16B
Total Debt579.88M
Net Debt-1.25M
Equity (Book Value)757.49M
Book Value Per Share3.47
Working Capital1.20B

Cash Flow

Insmed Incorporated produced -778.92M in operating cash flow over the past twelve months. After subtracting -28.75M in capital expenditures, free cash flow totaled -807.67M - equivalent to -3.76 per share.

Operating Cash Flow-778.92M
Capital Expenditures-28.75M
Free Cash Flow-807.67M
FCF Per Share-3.76

Margins

Insmed Incorporated operates with a gross margin of 83.46, reflecting its pricing power and cost economics. The operating margin of -71.43 and net profit margin of -76.94 provide insight into operational efficiency.

Gross Margin83.46
Operating Margin-71.43
Pretax Margin-76.40
Profit Margin-76.94
EBITDA Margin-69.69

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.53
FCF Yield-3.28

Stock Splits

Insmed Incorporated's most recent stock split took place on March 3, 2011 with a 10:1 split ratio.

Last Split Date3/3/2011
Split Ratio10:1

Scores

Insmed Incorporated posts an Altman Z-Score of 5.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.98